These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 19453346)

  • 1. Considerations before choosing (extemporaneously) compounded products.
    Krochmal L
    Dermatol Ther; 2009; 22(3):225-8. PubMed ID: 19453346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extemporaneous compounding. The end of the road?
    Ling MR
    Dermatol Clin; 1998 Apr; 16(2):321-7. PubMed ID: 9589205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective topical dermatologic therapy.
    Cullen SI
    Dermatol Clin; 1989 Jan; 7(1):37-42. PubMed ID: 2646048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New developments in extemporaneous formulations].
    Staubach P; Melhorn S; Hünerbein A; Peveling-Oberhag A
    Hautarzt; 2016 Oct; 67(10):833-844. PubMed ID: 27619802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label uses of biologic agents in dermatology: a 2006 update.
    Kerns MJ; Graves JE; Smith DI; Heffernan MP
    Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical use of systemic drugs in dermatology: a comprehensive review.
    Chiu HY; Tsai TF
    J Am Acad Dermatol; 2011 Nov; 65(5):1048.e1-22. PubMed ID: 21570151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sense and nonsense of extemporaneous formulations].
    Staubach P
    Hautarzt; 2014 Mar; 65(3):180-5. PubMed ID: 24424730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing dermatologic therapies.
    Wilkin J
    Dermatol Ther; 2009; 22(3):187-90. PubMed ID: 19453341
    [No Abstract]   [Full Text] [Related]  

  • 11. Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).
    Weaver J; Grenade LL; Kwon H; Avigan M
    Dermatol Ther; 2009; 22(3):204-15. PubMed ID: 19453344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yes to Appropriate Compounding, No to Illegal Compounding.
    Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s15-s16. PubMed ID: 30005108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding as a current therapeutic option in dermatology.
    Sánchez-Regaña M; Llambí-Mateos F; Salleras-Redonnet M; Iglesias Sancho M; Collgros Totosaus H; Umbert-Millet P
    Actas Dermosifiliogr; 2013 Nov; 104(9):738-56. PubMed ID: 22818830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounding is still appropriate in clinical practice.
    Thiers BH
    Dermatol Clin; 1998 Apr; 16(2):329-30. PubMed ID: 9589206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucocorticoid containing extemporaneous formulations. Rational for use in dermatology].
    Högger P
    Pharm Unserer Zeit; 2010 Jul; 39(4):294-9. PubMed ID: 20589803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug policy in Slovakia and its reflection in prescriptions. 2. Prescriptions of individually prepared drugs based on the medical specialty].
    Springer V; Kisska I
    Ceska Slov Farm; 2002 Jul; 51(4):186-9. PubMed ID: 12183906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical product design and extemporaneous compounding in dermatology.
    Krochmal L; Patel B
    Adv Dermatol; 1992; 7():231-52; discussion 253. PubMed ID: 1739582
    [No Abstract]   [Full Text] [Related]  

  • 18. What's new in dermatologic therapy.
    Thiers BH
    Dermatol Ther; 2008; 21(2):142-9. PubMed ID: 18394088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of biological agents in dermatology].
    Huryń A; Bielecka-Grzela S; Klimowicz A; Zejmo M
    Ann Acad Med Stetin; 2007; 53(2):8-13; discussion 13. PubMed ID: 18557371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S2k guidelines for the use of topical preparations on the skin.
    Wohlrab J; Staubach P; Augustin M; Eisert L; Hünerbein A; Nast A; Reimann H; Strömer K; Mahler V
    J Dtsch Dermatol Ges; 2018 Mar; 16(3):376-392. PubMed ID: 29537159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.